Salvinorin A attenuated forebrain ischemia-induced brain injury and edema.
Motor function on 1, 2 and 5 days and cognitive 5–9 days post-ischemia were improved by Salvinorin A.
Salvinorin A lessened forebrain ischemia-induced upregulation of AQP4 expression.
KOR may involve in the mechanism for Salvinorin A exerting neuroprotective effects.
Salvinorin A is a promising therapeutic agent for cerebral ischemia.